*Sponsored
Krypton Street Announces Coverage On Cosmos Health Inc. (NASDAQ:COSM) Starting Tomorrow Morning—Thursday, October 30, 2025
(COSM) Just Hit Our Radar—Tap Here To Get The Full Breakdown
Sent Direct To Your Mobile Device.
(COSM) Comes Backed By Several Potential Catalysts—But Here's What
We Can Tell You Tonight:
With Fewer Than 23M Shares Listed As Available, (COSM)'s Small Float Could See The Potential For Big Moves If Demand Begins To Shift.
(COSM) Moved Approximately 115% In Under A Month, From
Around $0.61 To $1.32.
(COSM) Is Advancing A $300M E-T-H Treasury Program To Integrate Block-Chain Innovation Into Healthcare.
(COSM) Is Currently Trending Around $1 And Appears To Be Flying
Under The Radar, Until Now…
Pull Up (COSM) Before Tomorrow Morning…
October 29, 2025
It's Under The Radar Tonight | But (COSM) Will Be Topping Tomorrow's Watchlist Dear Reader, The global nutraceuticals market is projected to exceed $1T within the next decade, reflecting sustained worldwide demand for products that promote long-term health and wellness. In the midst of this expansion, one little-known company—Cosmos Health Inc. (NASDAQ:COSM)—has quietly emerged as one of the most dynamic healthcare groups redefining the connection between science and everyday vitality. With momentum building, (COSM) will be topping our watchlist tomorrow morning —Thursday, October 30, 2025. The term nutraceuticals broadly refers to products derived from food sources that provide additional health benefits beyond basic nutritional value. These products are developed to support overall well-being, help regulate vital functions, and reduce the risk of chronic conditions — bridging the gap between nutrition and preventive healthcare. Recently, (COSM) secured a $300M financing facility to launch an Ethereum (ETH) digital assets treasury strategy, reflecting its forward-thinking approach to innovation and digital transformation. Earlier this month, (COSM) highlighted progress in its $300M E-T-H digital assets facility, announcing an additional $500K purchase on October 10, bringing its total holdings to $1.5M under the program. According to CEO Greg Siokas, the company is already seeing gains from earlier Ethereum investments and views digital assets like ETH not only as long-term holdings but also as potential enablers of secure, decentralized healthcare solutions. But here's what many overlook: (COSM) has fewer than 23M shares available in its public float, according to MarketWatch. When floats are this small, there's the potential for big moves if demand begins to shift. In fact, (COSM) recently made an approximate 115% move in under a month — from around $0.61 on September 8 to $1.32 on October 10. 
And while it continues to trend quietly around the $1 range, (COSM) is currently flashing 10 bullish signals on Barchart's technical analysis tool — suggesting underlying strength that's drawing fresh attention to the story. Through its network of subsidiaries — SkyPharm, CosmoFarm, Cana Laboratories, Decahedron, and ZipDoctor — Cosmos Health maintains an expanding presence across Europe, North America, and the Middle East. Its brands — Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept®, and C-Scrub® — are featured in pharmacies, retail stores, and major online platforms like Amazon and Holland & Barrett, now reaching over 2,000 locations in more than a dozen countries. With in-house manufacturing through Cana Laboratories, certified by the European Medicines Agency (EMA), Cosmos produces pharmaceuticals, supplements, and cosmetics under strict quality standards. The company is also advancing AI-powered research aimed at developing new solutions for obesity, diabetes, and cancer — combining technology and science to strengthen its position within the global nutraceutical landscape. Recent Developments Driving Momentum
Expanding Horizons: Sky Premium Life® Enters Kuwait's $1B+ Market
(COSM) expanded its Sky Premium Life® nutraceutical line into Kuwait through an exclusive agreement with Diyar United, a leading regional distributor. The deal includes an initial purchase order of over 65,000 units, targeting a market valued at $1.16B in 2024 and projected to grow to $1.68B by 2030. CEO Greg Siokas noted the partnership underscores growing global trust in Sky Premium Life® as it strengthens the brand's international reach. Entering The World's Largest Nutraceutical Market: U.S.
Operations Commence
Shortly before the Kuwait announcement, Cosmos Health launched its Sky Premium Life® brand in the United States, entering the $164B U.S. nutraceutical market.
Production takes place in FDA-registered and GMP-certified facilities, ensuring top-tier quality while supporting local operations. The debut product, Sky Premium Life NOOR Collagen, is projected to generate more than $12M in annualized revenue with approximately 75% gross margins, setting the stage for future product rollouts. Strengthening Its GCC Presence: Exclusive Distribution Deal in Oman
(COSM) signed a distribution agreement with Scientific Pharmacy LLC for Oman — the retail and wholesale arm of Planet Pharmacies, under Gulf Pharmaceutical Industries (Julphar). The agreement includes an initial 42,000-unit order and supports retail sales across Oman's healthcare network, expanding Cosmos Health's footprint within the fast-growing $7B GCC nutraceutical market. Digital Expansion: E-T-H Treasury Strategy Now In Motion
Following its August announcement, (COSM) has now purchased an additional $500K in E-T-H, raising total holdings to $1.5M. The acquisition aligns with the company's strategy to leverage block-chain in areas such as supply chain traceability, wellness incentives, and digital consumer engagement — while also diversifying its balance sheet with strategic digital assets. CEO Greg Siokas emphasized that the initiative is part of a long-term digital vision, integrating technology with healthcare innovation to build secure, decentralized systems for the future. Innovation Engine: Biotech and AI-Powered R&D
Cosmos Health (NASDAQ:COSM) is developing a pipeline of novel therapeutics and nutraceuticals, guided by its proprietary Cloudscreen® AI platform, which uses 3D and 1D structural analytics to accelerate discovery. Key programs include: - CCX0722, an innovative obesity and weight management formulation with appetite suppression and metabolism properties.
- CNS Cancer Program, focused on therapeutic repurposing for glioblastoma and other brain cancers, with patent filings submitted to EPO and WIPO.
- Anticancer Compounds targeting ovarian and prostate cancers, showing high preclinical activity against resistant cell lines.
(COSM) plans to spin off its biotech R&D division into a standalone public company, unlocking value from its growing intellectual property portfolio and expanding research partnerships across Europe. Building Momentum: Targeting $155M in Annual Revenue by 2027
According to its latest corporate presentation, (COSM) reported FY2024 estimated revenue of $55M+, with total assets of $65M and shareholder equity of $35M.
The company projects at least $155M in annual revenue and $30M in Adjusted EBITDA by 2027, supported by: - Expansion of CosmoFarm's wholesale network toward $90M in annual sales.
- Vertical integration through Cana Laboratories and new manufacturing contracts.
- Growth of Sky Premium Life®, Mediterranation®, C-Sept®, and OTC portfolios.
- Cost efficiencies from group-wide optimization and technology adoption.
Leadership with Deep Sector Expertise
Under the leadership of CEO Greg Siokas, who has personally invested over $17M into the company, Cosmos Health continues to execute an ambitious expansion strategy. The management team brings expertise across pharma, M&A, and biotechnology, supported by independent directors with capital markets experience — reinforcing accountability and long-term vision. A Company Positioned for Global Acceleration
(COSM)'s steady progress — from AI-driven R&D to international expansion and now block-chain integration — highlights its unique blend of science, scalability, and execution. Its Sky Premium Life® brand continues to gain traction in high-quality wellness products, while its growing ETH holdings underscore a commitment to digital innovation and financial modernization. With expanding operations across the U.S., Europe, and the Middle East, and potential biotech spin-off plans ahead, (COSM) represents a healthcare innovator entering a powerful new phase supported by technology, science, and strategy. 7 Reasons Why (COSM) Will Be Topping Our Watchlist Tomorrow
Morning—Thursday, October 30, 2025
1. Small Float: With fewer than 23M shares available, (COSM)'s small float could lead to the potential for big moves if demand begins to shift. 2. Recent Momentum: Over the past month, (COSM) made an approximate 115% move — from around $0.61 to $1.32 — demonstrating how quickly momentum can build around emerging names. 3. Digital Expansion: Through a $300M E-T-H treasury facility, (COSM) is incorporating block-chain innovation into its long-term healthcare and wellness strategy. 4. Global Reach: With operations across the U.S., Europe, and the Middle East, (COSM) continues to expand distribution for its Sky Premium Life® and Mediterranation® brands. 5. AI Integration: Using its proprietary Cloudscreen® AI platform, (COSM) is advancing research aimed at creating new formulations for major health and wellness challenges. 6. Strong Growth Outlook: According to its latest corporate presentation, (COSM) projects at least $155M in annual revenue and $30M in Adjusted EBITDA by 2027. 7. Under The Radar: Despite expanding across three continents and advancing in AI and block-chain, (COSM) remains largely overlooked and is currently trending around $1 — a quietly growing healthcare name building early momentum. Pull Up (COSM) Before Tomorrow Morning…
With a tight float, expanding operations, a growing digital treasury, and rising attention in both healthcare and block-chain circles, Cosmos Health (NASDAQ:COSM) continues to stand out. After an approximate 115% move and 10 bullish signals, the potential for momentum may be building beneath the surface. We'll have all eyes on (COSM) tomorrow morning. Take a look before you call it a night. Also, keep a lookout for my morning update. Have a good night. Sincerely,
Alex Ramsay
Co-Founder / Managing Editor
Krypton Street Newsletter | 
